Mónica Muñoz - Concepedia

Author

Mónica Muñoz

Center for Drug Evaluation and Research ORCID

Also Known As

M Munoz, M Muñoz, M Muñóz, M. A. Suárez Muñoz, M. Muñoz, Manuela Galvis Muñoz, Monica A Munoz, Monica A Muñoz, Monica A. Munoz, Monica A. Muñoz

Publications

722

Citations

H-Index

Concepts

All Affiliations

Center for Drug Evaluation and Research United States Food and Drug Administration Harvard University University of Florida Florida College

About

Mónica Muñoz is an author at Center for Drug Evaluation and Research specializing in medicine, pharmacovigilance, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	203
2	Public Health	3	3	88
3	Emergency Medicine	2	2	49
4	Engineering	1	1	26
5	Management	1	1	17

Mónica Muñoz

Publications

544

Citations

H-Index

Page 1

	Year	Citations
Management of acquired rectourinary fistulas Mónica Muñoz, Heidi Nelson, J. R. Harrington, Diseases of the Colon & Rectum	1998	73
Toxicology evaluation of a procyanidin-rich extract from grape skins and seeds Laura Lluís, Mónica Muñoz, María Rosa Nogués, Food and Chemical Toxicology PolyphenolicsMedicineProcyanidin-rich ExtractPhytopharmacologyToxicology	2011	66
Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System Kory Kreimeyer, Oanh Dang, Jonathan Spiker, Computers in Biology and Medicine Systems PharmacologyEpidemiologyHealth InformaticsMachine LearningHealth Policy	2021	45
Imaging Techniques Contribute to Increased Surgical Rescue of Relapse in the Follow-Up of Colorectal Cancer Edurne Arriola, Matilde Navarro, David Parés, Diseases of the Colon & Rectum	2006	39
Liver injury associated with dimethyl fumarate in multiple sclerosis patients Mónica Muñoz, Corrinne G. Kulick, Cindy Kortepeter, Multiple Sclerosis Journal	2017	32
Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs Justin Bohn, Cindy Kortepeter, Mónica Muñoz, Clinical Pharmacology & Therapeutics	2015	27
Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility Mónica Muñoz, Gerald J. Dal Pan, Yu‐Jung Jenny Wei, Drug Safety Prediction ModelEngineeringData MiningAdverse EventPredictive Analytics	2020	26
Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration David Croteau, Ellen Pinnow, Eileen Wu, Drug Safety Drug SafetyPreventive MedicineEvidence TriggeringUs FoodFood Labels	2022	26
An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System Kathryn K. Marwitz, S. Christopher Jones, Cindy Kortepeter, Drug Safety Post-marketing SurveillanceHealth PolicyAdverse EventClinical EndpointPatient Safety	2020	23
Comparative Effectiveness of Fish Oil Versus Fenofibrate, Gemfibrozil, and Atorvastatin on Lowering Triglyceride Levels Among HIV-Infected Patients in Routine Clinical Care Mónica Muñoz, Wei Liu, Joseph A. Delaney, JAIDS Journal of Acquired Immune Deficiency Syndromes	2013	21

Page 1